SCHEMBL7991535

SCHEMBL7991535

Cc1ccc(Cn2cnc3[nH]c(-c4ccccn4)nc(=O)c32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 4/20 0.43
PARN O95453 1/20 0.43
METAP2 P50579 2/20 0.41
METAP1 P53582 2/20 0.41
CBFB Q13951 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 2/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
PKM P14618 1/20 0.40
MCL1 Q07820 1/20 0.40
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
OPRK1 P41145 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985494 0.91 CNOT7 (0.52) CNOT7PARNMETAP2METAP1SMN1; SMN2
SCHEMBL7974054 0.89 EGLN1 (0.44) CNOT7PARNMETAP2METAP1CBFB
SCHEMBL7991792 0.89 ALDH1A1 (0.44) CNOT7PARNMETAP2METAP1CBFB
SCHEMBL7991661 0.89 ABCC8 (0.45) CNOT7PARNMETAP2METAP1SMN1; SMN2
SCHEMBL7984720 0.85 CNOT7 (0.48) CNOT7PARNSMN1; SMN2LMNAHTT
SCHEMBL7992180 0.84 SMN1; SMN2 (0.45) CNOT7PARNMETAP2METAP1CBFB
SCHEMBL7991530 0.83 HPGD (0.48) METAP2METAP1CBFBSMN1; SMN2LMNA
SCHEMBL7985827 0.82 CNOT7 (0.49) CNOT7PARNSMN1; SMN2LMNAHTT
SCHEMBL7974009 0.82 METAP2 (0.41) CNOT7PARNMETAP2METAP1CBFB
SCHEMBL7985461 0.82 TP53 (0.48) LMNANPC1RAB9AGAANPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed